| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/28/1992 | US5134121 Nerve growth factor peptides |
| 07/28/1992 | US5134076 Monoclonal antibodies specific for protease nexin-1 and puriciation of protease nexin-1 using monoclonal antibodies |
| 07/28/1992 | US5134075 Antitumor agents |
| 07/28/1992 | US5134065 Tissue plasminogen activator inhibitor and method of purification |
| 07/28/1992 | US5133978 Thickening, Buttermilk, Sour Cream |
| 07/28/1992 | US5133962 Method of controlling coleopteran insects with Bacillus thuringiensis |
| 07/28/1992 | US5133961 Immunology |
| 07/28/1992 | CA1305829C Ovine inhibin |
| 07/28/1992 | CA1305828C Synthetic peptides and use for diagnosis and vaccination for aids and arc |
| 07/28/1992 | CA1305681C Fluidized bioreactor and cell cultivation process |
| 07/28/1992 | CA1305678C Recombinant dna clone encoding laminin receptor |
| 07/26/1992 | WO1992012727A1 Laminin a chain domain vi polypeptides |
| 07/26/1992 | CA2101052A1 Laminin a chain domain vi polypeptides |
| 07/26/1992 | CA2057547A1 Vav proto-oncogene protein |
| 07/25/1992 | CA2059904A1 Peptides |
| 07/25/1992 | CA2059380A1 Endothelin receptor antagonists isolated from microbispora |
| 07/23/1992 | WO1992012999A1 Novel insulin analogs |
| 07/23/1992 | WO1992012430A1 Prescreening of prostate cancer by serum prostatic specific antigen |
| 07/23/1992 | WO1992012260A1 METHOD OF DESCRIBING REPERTOIRES OF ANTIBODIES (Ab) AND T CELL RECEPTORS (TcR) OF THE IMMUNE SYSTEM OF AN INDIVIDUAL |
| 07/23/1992 | WO1992012248A1 Biological remediation of creosote and similarly-contaminated sites |
| 07/23/1992 | WO1992012246A1 Nucleotidic sequences coding for the murine adrenergic beta 3 receiver and applications thereof |
| 07/23/1992 | WO1992012245A1 Human bfgf derivatives, their analogs and process for their production |
| 07/23/1992 | WO1992012244A1 Genes which code for guinea pig and human platelet activating factor receptors |
| 07/23/1992 | WO1992012242A1 Modified hepatocytes and uses therefor |
| 07/23/1992 | WO1992012240A1 Interferon sensitive recombinant poxvirus vaccine |
| 07/23/1992 | WO1992012176A1 Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof |
| 07/23/1992 | WO1992012175A1 Cytokine-induced protein, tsg-6, dna coding therefor and uses thereof |
| 07/23/1992 | WO1992012173A1 A method for constructing antigens |
| 07/23/1992 | WO1992012172A1 Amides of antibiotic ge 2270 factors |
| 07/23/1992 | WO1992012170A1 Inhibitions of endothelin formation |
| 07/23/1992 | WO1992012167A1 Protection group, compoud protected by this group and device for grafting the protection group onto the compound being protected |
| 07/23/1992 | WO1992012163A1 A method for determining the nucleotide sequence of the gene for the alpha5(iv) chain of human type iv collagen |
| 07/23/1992 | WO1992011868A1 Protective malaria sporozoite surface protein immunogen and gene |
| 07/23/1992 | WO1992011866A1 LAMININ SEQUENCE AS tPA ACTIVATOR |
| 07/23/1992 | WO1992011859A1 Peptide-mediated hyposensitization of the human t cell response to dermatophagoides spp. (house dust mite) |
| 07/23/1992 | WO1992011770A1 Method for separation of lactoserum proteins and products thus obtained |
| 07/23/1992 | WO1992011753A1 Genetically engineered mice containing alterations in the mhc class ii genes |
| 07/23/1992 | WO1992008792A3 Method for increasing and activating monocytes and neutrophils and for inducing maturation of myeloid cells with interleukin-5 |
| 07/23/1992 | WO1992005266A3 Packaging cells |
| 07/23/1992 | CA2100565A1 Insulin analogs |
| 07/23/1992 | CA2099120A1 Protection group, compound protected by this group and device for grafting the protection group onto the compound being protected |
| 07/23/1992 | CA2099001A1 Genetically engineered mice containing alterations in the mhc class ii genes |
| 07/23/1992 | CA2076848A1 Modified hepatocytes and uses therefor |
| 07/22/1992 | EP0495674A2 TGF-beta induced gene family |
| 07/22/1992 | EP0495639A1 Use of interleukin-10 in adoptive immunotherapy of cancer |
| 07/22/1992 | EP0495638A2 Expression of mature PDGF-B in Escherichia coli |
| 07/22/1992 | EP0495347A1 Method for separating glycosylated hemoglobin HB A1C by electrophoresis on agarose gel |
| 07/22/1992 | EP0495265A1 Acid-labile linker molecules |
| 07/22/1992 | EP0495131A1 Agent for preventing and treating hepatitis |
| 07/22/1992 | EP0495096A1 Plant fatty acid synthases |
| 07/22/1992 | EP0495064A1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 07/22/1992 | EP0495052A1 Allergens of alder pollen and applications thereof |
| 07/22/1992 | EP0495050A1 Granulocyte-inhibiting polypeptide |
| 07/22/1992 | EP0495049A1 Process for the enzymatic preparation of basic fibroblast growth factor. |
| 07/22/1992 | EP0495014A1 Novel oxidized lipoproteins and methods for their preparation |
| 07/22/1992 | EP0494998A1 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
| 07/22/1992 | EP0494992A1 Methods and apparatus for treating disease states using oxidized lipoproteins |
| 07/22/1992 | EP0494973A1 Compounds useful for measuring low levels of sulfonylureas by immunoassay |
| 07/22/1992 | EP0451206A4 Receptor transcription-repression activity compositions and methods |
| 07/22/1992 | EP0406281B1 Gestation-recognizing protein |
| 07/22/1992 | EP0327548B1 Glycopeptide antibiotics |
| 07/21/1992 | US5132408 Polypeptides |
| 07/21/1992 | US5132404 Method of purifying human serum albumin using organic carboxylic acids and acetyl tryptophan |
| 07/21/1992 | US5132403 Forms complex with interleukin-6 receptor; genetic engineering |
| 07/21/1992 | US5132402 Adsorbent, method for production thereof, and method for use thereof |
| 07/21/1992 | US5132401 MB-35 a peptide enhancing the production of growth hormone and prolactin from the anterior pituitary |
| 07/21/1992 | US5132400 Peptides containing a (1-amino-2-hydroxy-2-heterocyclic)ethyl moiety |
| 07/21/1992 | US5132296 Membrane NA+ channel protein and related therapeutic compounds |
| 07/21/1992 | US5132287 Methods of treating disorders which cause conglutinin deficiency |
| 07/21/1992 | US5132215 Method of making double-stranded dna sequences |
| 07/21/1992 | US5132213 Method for producing proteins and polypeptides using ubiquitin fusions |
| 07/21/1992 | US5132212 Scl gene, and a hematopoietic growth and differentiation factor encoded thereby |
| 07/21/1992 | US5132205 High ph extraction composition and its use to determine a chlamydial, gonococcal or herpes antigen |
| 07/21/1992 | US5132111 Corticotropin-releasing factor polypeptide antagonists |
| 07/21/1992 | US5132110 Treatment of neoplastic disease, administering modified interferon, raising body temperature |
| 07/21/1992 | US5132109 Method for inhibiting production of ige and method for enhancing production of igg using interleukin 9 and inhibitors thereof |
| 07/21/1992 | CA1305416C Method of isolating ca 125 antigen |
| 07/21/1992 | CA1305415C Method of purifying toxin conjugates using hydrophobic interaction chromatography |
| 07/21/1992 | CA1305413C Process for producing a coagulation active complex of factor viii fragments |
| 07/19/1992 | WO1992013097A1 Hepatic growth factor receptor is the met proto-oncogene |
| 07/19/1992 | CA2059596A1 Tfg-beta induced gene family |
| 07/18/1992 | WO1992012998A1 Methods for detecting glucagon antagonists |
| 07/18/1992 | WO1992012722A1 Antifreeze glycopeptide compositions to protect cells and tissues during freezing |
| 07/18/1992 | CA2100874A1 Methods for detecting glucagon antagonists |
| 07/17/1992 | WO1992012993A1 Method for the purificatioin of intact, correctly-folded insulin-like growth factor-1 |
| 07/15/1992 | WO1992012174A1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 07/15/1992 | EP0494825A1 Synthetic peptides, derived from HBc antigen of hepatitis B virus |
| 07/15/1992 | EP0494702A2 Production of factor XIIIa by gene technology |
| 07/15/1992 | EP0494664A1 Human bFGF derivatives, their analogs and process for their production |
| 07/15/1992 | EP0494515A1 Antibiotic cyclic hexapeptide |
| 07/15/1992 | EP0494502A1 Method for surmising functional site in physiologically active polypeptide or polynucleotide |
| 07/15/1992 | EP0494317A1 The retrovirus SIV cpz-ant and its uses |
| 07/15/1992 | EP0494293A1 Monoclonal antibody to enterohemorrhagic escherichia coli 0157:h7 and 026:h11 and method for detection |
| 07/15/1992 | EP0494258A1 Method of excising and propagating genomic dna |
| 07/15/1992 | EP0494246A1 Gene conferring salt tolerance |
| 07/15/1992 | EP0494244A1 Therapeutic ribozyme compositions and expression vectors |
| 07/15/1992 | EP0494228A1 Ribozymzusammensetzungen und deren verwendung |
| 07/15/1992 | EP0494175A1 Compositions for cell adhesion inhibition and methods of use |
| 07/15/1992 | EP0494158A1 A recombinant birth control vaccine |
| 07/15/1992 | EP0494135A1 DETECTION AND QUANTIFICATION OF -i(NEU) RELATED PROTEINS IN THE BIOLOGICAL FLUIDS OF HUMANS. |